PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation

This study has been completed.

Study NCT00326157 Information provided by Gilead Sciences

First Received: May 10, 2006 Last Updated: February 11, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2009
Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)